Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Tredaptive (niacin/laropiprant) on postprandial lipoprotein and glucose metabolism in severe dyslipoproteinemia
2010-019954-42Phase 4Terminated
- Sponsor
- LMU Klinikum, Department of Internal Medicine II
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of laropiprant in dyslipidemia, sponsored by LMU Klinikum, Department of Internal Medicine II. Primary endpoint: Incremental area under the plasma triglyceride curve. Started Jul 2010; status: terminated.
02
Drugs
laropiprant
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on 2010-019954-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019954-42.